The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 105.40
Bid: 105.00
Ask: 105.60
Change: -0.20 (-0.19%)
Spread: 0.60 (0.571%)
Open: 107.20
High: 107.60
Low: 104.40
Prev. Close: 105.60
PZC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

23 Sep 2020 07:00

RNS Number : 7963Z
PZ CUSSONS PLC
23 September 2020
 

 

23rd September 2020

 

Trading update

 

PZ Cussons Plc ("PZ Cussons" or the "Group") today issues the following trading update in respect of the first quarter ended August 31st 2020.

 

Good start with revenue growth but volatility ahead

 

· Q1 Revenue growth of 23% with Focus Brands growth of 37% at constant rates of exchange

· Driven by top line focused interventions and strong demand for hygiene brands

· Continued excellent performance in the UK and Indonesia

· Recovery of results in Australia, Nigeria and Beauty

· Balance sheet further strengthened with net debt lower than year-end

· In Nigeria, the disposal of our Nutricima milk business is on track with expected completion by end of September

· Reviewing our strategy for sustainable growth as a leading branded consumer goods business

 

Jonathan Myers, Chief Executive Officer commented:

 

The first quarter results have given us a good start to the year with growth in all three regions and an improvement in profitability. The majority of our Focus Brands are now in growth, led by Carex in the UK. In the second quarter we plan to increase investment further in building our brands and capabilities. We are currently in a process to examine and evolve our strategy to deliver sustainable top line growth and improved operating margin.

 

The operating landscape remains highly volatile with many of the economies we operate in moving into recession, the continuing uncertainty of the COVID-19 pandemic and categories remaining highly competitive with pressure on discounting and cost. While it remains very difficult to forecast and give guidance we expect some adverse headwinds for the rest of the year following this good start.

 

We continue to take the appropriate steps to safeguard our employees with their health and wellbeing remaining of paramount importance to us. Finally we continue to secure the business for the future and both the work on strategy and focus on liquidity reflects this.

 

Trading update

 

 

£m

Growth versus last year (Reported)

Growth versus last year (Constant fx)

Europe & Americas

61.5

+49%

+49%

Asia Pacific

48.9

+6%

+9%

Africa

47.7

+4%

+13%

Group

158.1

+19%

+23%

 

Europe and Americas delivered strong revenue growth in Q1 driven by results in our Personal Care category and recovery in Beauty. Carex remains the driver with market share in UK hand wash increasing to circa 40% in hand wash and clear leadership of the growing hand sanitizer market in the UK. Original Source and Imperial leather both saw revenue decline in the quarter compared to last year and we will look to strengthen our plans for these brands in this financial year.

 

Beauty continues to recover with revenue modestly ahead of last year for the first quarter driven by a stronger on-line performance which now accounts for around 36% of our business with both ST Tropez and Sanctuary delivering good revenue growth.

 

Asia Pacific grew revenue in both Australia and Indonesia in the first quarter. Indonesia continues to deliver good performance with Cussons Baby despite lower footfall in modern trade as well as wider economic issues. In Australia Morning Fresh achieved record market share and together with Radiant performed strongly in the quarter. Rafferty's Garden stabilised in the first quarter.

 

Africa grew revenue compared to last year with Nigeria returning to more normal trading patterns following the removal of restrictions as a result of COVID-19. Premier grew revenue in the first quarter supported by recent relaunches, Morning Fresh continued to deliver strong results and Cussons Baby returned to growth. The region returned to profit in the first quarter despite the continuing adverse economic situation and an increase in input costs driven by the scarcity of foreign currency.

 

Liquidity remains strong for the Group and net debt further reduced compared to the year-end.

 

COVID-19 Update

 

Our employees' health and wellbeing remains a key focus for us during this pandemic. Our manufacturing sites have all remained open and operational since the outbreak and together with our teams working from home reflects the fantastic commitment throughout the business. We continue to take very seriously our role in the wider society supporting those most at need through programmes in all our markets.

 

The environment continues to remain volatile in our markets with adverse economic headwinds in the UK, Nigeria, Australia and Indonesia. Our Personal and Home Care brands have been energised and refocused by the opportunities in hygiene-related categories but competition remains strong in addition to COVID-19 related risk of volatility in our supply chain.

 

Outlook

 

COVID-19 and its aftermath in terms of both economic factors and consumer confidence will clearly continue to have a significant impact on the consumption of our Personal Care, Home Care and Beauty products.

 

Despite the renewed momentum of our business in the first quarter we expect volatility and risk to continue as well as increased investment in our brands and capabilities as we prepare for a multi-year turnaround of the business, starting with a comprehensive review of our strategy.

 

- Ends -

 

Press enquiries:

 

PZ Cussons - Alan Bergin (Interim Chief Financial Officer) 0161 435 1236

Instinctif - Tim Linacre / Guy Scarborough 020 7457 2020

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUUSRRROUKUUR
Date   Source Headline
10th May 202410:00 amRNS2023 AGM Voting Results Update Statement
24th Apr 20247:00 amRNSQ3 Trading and update on strategic actions
19th Apr 20248:49 amRNSDirector/PDMR Shareholding
12th Apr 202411:04 amRNSDirector/PDMR Shareholding
8th Apr 20245:29 pmRNSDirector/PDMR Shareholding
19th Mar 202410:30 amRNSDirector/PDMR Shareholding
23rd Feb 20243:47 pmRNSDirector/PDMR Shareholding
19th Feb 20243:18 pmRNSDirector/PDMR Shareholding
8th Feb 20243:40 pmRNSDirector/PDMR Shareholding
8th Feb 20243:09 pmRNSDirector/PDMR Shareholding
8th Feb 20243:07 pmRNSDirector/PDMR Shareholding
7th Feb 20247:00 amRNS2024 Interim Results
19th Jan 202410:50 amRNSDirector/PDMR Shareholding
15th Jan 20247:00 amRNSDirectorate Change
18th Dec 20233:10 pmRNSDirector/PDMR Shareholding
4th Dec 20233:03 pmRNSDirector/PDMR Shareholding
4th Dec 20237:00 amRNSDirectorate Change
29th Nov 202312:10 pmRNSDirector/PDMR Shareholding
29th Nov 202312:08 pmRNSDirector/PDMR Shareholding
23rd Nov 20235:57 pmRNSResult of AGM
23rd Nov 20237:00 amRNSAGM Trading Statement
20th Nov 20231:58 pmRNSDirector/PDMR Shareholding
19th Oct 202310:00 amRNSDirector/PDMR Shareholding
10th Oct 202311:10 amRNSDirector/PDMR Shareholding
5th Oct 20233:44 pmRNSHolding(s) in Company
27th Sep 202310:00 amRNSPreliminary Results - Correction
26th Sep 20237:00 amRNSPZ Cussons Preliminary Results
20th Sep 202311:09 amRNSDirector/PDMR Shareholding
5th Sep 20237:00 amRNSAcquisition of minority ownership of PZCN Plc
21st Aug 20232:07 pmRNSDirector/PDMR Shareholding
26th Jul 20239:22 amRNSDirector/PDMR Shareholding
19th Jul 202310:23 amRNSDirector/PDMR Shareholding
11th Jul 20232:06 pmRNSDirector/PDMR Shareholding
4th Jul 20237:00 amRNSCapital Markets Event
30th Jun 20232:18 pmRNSDirector/PDMR Shareholding
29th Jun 202311:06 amRNSDirector/PDMR Shareholding
27th Jun 20237:00 amRNSTrading Statement
21st Jun 20239:59 amRNSDirector/PDMR Shareholding
16th Jun 20237:00 amRNSDirectorate Change
19th May 20239:27 amRNSDirector/PDMR Shareholding
21st Apr 20239:00 amRNSIntention to Conduct Audit Tender
19th Apr 202310:01 amRNSDirector/PDMR Shareholding
13th Apr 20233:18 pmRNSHolding(s) in Company
13th Apr 20237:00 amRNSQ3 Trading Update
12th Apr 20232:18 pmRNSDirector/PDMR Shareholding
24th Mar 20237:00 amRNSDirectorate Change
21st Mar 20239:30 amRNSDirector/PDMR Shareholding
17th Mar 20234:35 pmRNSPrice Monitoring Extension
21st Feb 20239:31 amRNSDirector/PDMR Shareholding
8th Feb 20237:00 amRNS2023 Interim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.